[
    [
        {
            "time": "",
            "original_text": "白雲山(00874)擬向甘肅中藥科技增資1.18億元用於甘肅廣藥白雲山中藥科技產業園(一期)項目建設",
            "features": {
                "keywords": [
                    "白雲山",
                    "甘肅中藥科技",
                    "增資",
                    "1.18億元",
                    "中藥科技產業園",
                    "一期項目"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "醫藥",
                    "中藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山(00874)擬向甘肅中藥科技增資1.18億元用於甘肅廣藥白雲山中藥科技產業園(一期)項目建設",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "白雲山(600332.SH)：擬使用1.18億元募集資金通過子公司向甘肅中藥科技增資",
            "features": {
                "keywords": [
                    "白雲山",
                    "募集資金",
                    "子公司",
                    "甘肅中藥科技",
                    "增資"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "醫藥",
                    "中藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山(600332.SH)：擬使用1.18億元募集資金通過子公司向甘肅中藥科技增資",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "白雲山(600332.SH)擬向子公司增資用於甘肅中藥科技產業園(一期)項目建設",
            "features": {
                "keywords": [
                    "白雲山",
                    "子公司",
                    "增資",
                    "甘肅中藥科技產業園",
                    "一期項目"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "醫藥",
                    "中藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山(600332.SH)擬向子公司增資用於甘肅中藥科技產業園(一期)項目建設",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "白雲山：使用募集資金向全資子公司增資暨全資子公司向全資孫公司增資",
            "features": {
                "keywords": [
                    "白雲山",
                    "募集資金",
                    "全資子公司",
                    "全資孫公司",
                    "增資"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "醫藥",
                    "中藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山：使用募集資金向全資子公司增資暨全資子公司向全資孫公司增資",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        }
    ]
]